Email not displaying correctly? View it in your browser.
Mayo Clinic Clinical Update e-Edition
November 2014
Follow us:   Facebook icon Twitter icon Youtube icon  
anchor arrowResearch | anchor arrowEducation | anchor arrowIn the Video Center | anchor arrowConsults & Referrals | anchor arrowResources
Less Radical Procedures Offer Similar Cancer Control Compared to Surgery for Kidney Cancer Patients
Patient Care

American Thyroid Association revises thyroid cancer management guidelines

Thyroid cancer management is revolving rapidly, to a more minimalistic, individualized approach for low-risk patients, and to more-targeted and evidence-based therapeutic approaches for advanced-stage disease.


Lower cisplatin dosage may not affect medulloblastoma survival
Although credited with boosting survival rates for children with medulloblastoma, cisplatin-based adjuvant chemotherapy carries significant risks. Research at Mayo Clinic shows no significant differences in event-free survival and overall survival among patients who receive varying cumulative cisplatin doses.

Tuft cells implicated in pancreatic neoplasia

Research has shown that tuft cells act as tumor-initiating cells for pancreatic neoplasia. Now, Mayo Clinic researchers have found that SOX17 expression, both alone and combined with the KRAS oncogene, greatly increases this tumor-initiating ability.

Collaborative study supports accuracy of genomic sequencing

RNA sequencing is used with increasing frequency to characterize a growing array of conditions. A study by 150 researchers in 12 countries found agreement across RNA genomic sequencing techniques and laboratories and ways to improve what little variability exists to set a new high standard.

See all Cancer Clinical Trials at Mayo Clinic

Back To Top

Clinical and Multidisciplinary Hematology and Oncology 2015: The 12th Annual Review
Jan. 23-25, 2015, in Scottsdale, Ariz.
This comprehensive update of issues in hematologic and oncologic malignancies presents new disease classification, treatment and challenging cases. Topics include hematologic diseases such as dysproteinemias, acute and chronic leukemias and lymphomas, plus supportive, ancillary and diagnostic care.

Mayo Clinic Hematology Review
Jan. 24, 2015, in Minneapolis
Programming provides hematology and oncology clinicians, nurse practitioners, and physician assistants with an overview of advances in the treatment of various hematologic malignancies, based on abstracts presented at the December 2014 annual meeting of the American Society of Hematology.

See all Hematology & Oncology Continuous Professional Development courses

Back To Top
In the Video Center

Targeting Improved Survival in Anaplastic Thyroid Cancer
Keith C. Bible, M.D., Ph.D., discusses basic, translational and therapeutic innovations originating at Mayo Clinic and used in the treatment of patients with anaplastic thyroid cancer.

View videos by specialty and Grand Rounds presentations online

Back To Top
In the News

Back To Top
Consults & Referrals

Back To Top

Back To Top

Comments Comments?
We're interested in your feedback about this newsletter
Mayo Clinic

13400 East Shea Blvd.
Scottsdale, AZ 85259

4500 San Pablo Road
Jacksonville, FL 32224

200 First St. SW
Rochester, MN 55905

Share Pass It On!
Invite a friend to subscribe by forwarding this newsletter

Mayo Clinic shield logo | Newsletter Archive | Contact | Medical Professionals

© 2014 Mayo Foundation for Medical Education and Research
200 First Street SW, Rochester, MN 55905. All rights reserved.
Terms of Use